AUDREY GLOVER: Open Payments
NPI 1285979682 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 85 payments from 18 companies in 2025. Trend: 2023 $2,562 · 2024 $2,786 · 2025 $1,986
Food & beverage: $1,941Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $450 |
| Amgen Inc. | 12 | $316 |
| PFIZER INC. | 10 | $231 |
| AstraZeneca Pharmaceuticals LP | 7 | $227 |
| Janssen Biotech, Inc. | 18 | $218 |
| UCB, Inc. | 10 | $184 |
| Fresenius Kabi USA, LLC | 2 | $46 |
| Lilly USA, LLC | 1 | $45 |
| Fidia Pharma USA Inc. | 2 | $41 |
| Invivyd Inc | 1 | $34 |
Products named: RINVOQ, XELJANZ, TREMFYA, EVENITY, SAPHNELO, Bimzelx, SKYRIZI, OTEZLA.
Industry payments across NY — which companies pay providers there.
